Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-22

Clinical Trial Update: Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038) [NA]

View source ↗

Summary

Update on a Merck clinical trial studying management strategies for patients at high risk of osteoporotic fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Osteoporosis | NA | Status: COMPLETED